These authors contributed equally to this study.
The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type†
Article first published online: 25 SEP 2009
Copyright © 2009 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
The Journal of Pathology
Volume 220, Issue 1, pages 45–57, January 2010
How to Cite
Weigelt, B., Geyer, F. C., Natrajan, R., Lopez-Garcia, M. A., Ahmad, A. S., Savage, K., Kreike, B. and Reis-Filho, J. S. (2010), The molecular underpinning of lobular histological growth pattern: a genome-wide transcriptomic analysis of invasive lobular carcinomas and grade- and molecular subtype-matched invasive ductal carcinomas of no special type. J. Pathol., 220: 45–57. doi: 10.1002/path.2629
No conflicts of interest were declared.
- Issue published online: 2 DEC 2009
- Article first published online: 25 SEP 2009
- Accepted manuscript online: 25 SEP 2009 12:00AM EST
- Manuscript Accepted: 17 SEP 2009
- Manuscript Revised: 13 SEP 2009
- Manuscript Received: 4 AUG 2009
- Breakthrough Breast Cancer
- Cancer Research UK Fellowship
- NIHR Biomedical Research Centre
- 1Invasive breast carcinoma. In WHO Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs, TavassoliFA, DevileeP (eds). Lyon Press: Lyon, 2003; 13–59., , , , , , et al.
- 2In situ and invasive lobular neoplasia of the breast. Histopathology 2008; 52:: 58–66., .
- 3Refinement of breast cancer classification by molecular characterization of histological special types. J Pathol 2008; 216: 141–150., , , , , , et al.
- 4Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res 2004; 6: R149–R156., , , .
- 5Lack of prognostic significance of ‘classic’ lobular breast carcinoma: a matched, single institution series. Breast Cancer Res Treat 2009; 117:: 211–214., , , , , , et al.
- 6Pleomorphic lobular carcinoma of the breast: an aggressive tumor showing apocrine differentiation. Hum Pathol 1992; 23: 655–662., , .
- 7Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol 1992; 23: 1167–1171., .
- 8Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol 2005; 207: 1–13., , , , , , et al.
- 9Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas. J Pathol 2008; 215: 231–244., , , , , , et al.
- 10Pleomorphic lobular carcinoma of the breast: its cell kinetics, expression of oncogenes and tumour suppressor genes compared with invasive ductal carcinomas and classical infiltrating lobular carcinomas. Histopathology 2001; 39: 503–513., , .
- 11Preferential HER-2/neu overexpression and/or amplification in aggressive histological subtypes of invasive breast cancer. Histopathology 2004; 44: 332–338., , , , .
- 12Pleomorphic lobular carcinoma of the breast: molecular pathology and clinical impact. Future Oncol 2009; 5: 233–243., , .
- 13Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. J Clin Oncol 2005; 23: 41–48., , , , , , et al.
- 14Neoadjuvant chemotherapy in invasive lobular carcinoma may not improve rates of breast conservation. Ann Surg Oncol 2009; 16: 1606–1611., , , , , , et al.
- 15Primary systemic chemotherapy of invasive lobular carcinoma of the breast. Lancet Oncol 2007; 8: 55–62., , , .
- 16Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma. Eur J Surg Oncol 2003; 29: 361–367., , , , , , et al.
- 17Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution. Ann Oncol 2006; 17: 1228–1233., , , , , , et al.
- 18E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. EMBO J 1995; 14: 6107–6115., , , , , , et al.
- 19Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast. Int J Cancer 2001; 92: 404–408., , , , , .
- 20Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int J Cancer 2003; 106: 208–215., , , , , , et al.
- 21Reduction of E-cadherin expression is associated with non-lobular breast carcinomas of basal-like and triple negative phenotype. J Clin Pathol 2008; 61: 615–620., , , .
- 22Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions. Oncogene 2004; 23: 3272–3283., , , , , , et al.
- 23The spectrum of morphomolecular abnormalities of the E-cadherin/catenin complex in pleomorphic lobular carcinoma of the breast. Appl Immunohistochem Mol Morphol 2007; 15: 260–266., , , , , .
- 24Dysregulation of the E-cadherin/catenin complex by irreversible mutations in human carcinomas. Cell Adhes Commun 1998; 6: 171–184., , .
- 25Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. J Pathol 1997; 183: 404–411., , , , , , et al.
- 26Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. Cancer Res 2003; 63: 7167–7175., , , , , , et al.
- 27Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Mol Biol Cell 2004; 15: 2523–2536., , , , , , et al.
- 28Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 2007; 7: 55., , , , , , et al.
- 29Lobular and ductal carcinomas of the breast have distinct genomic and expression profiles. Oncogene 2008; 27: 5359–5372., , , , , , et al.
- 30The role of molecular analysis in breast cancer. Pathology 2009; 41: 77–88., , .
- 31Gene-expression signatures in breast cancer. N Engl J Med 2009; 360: 790–800., .
- 32Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006; 98: 262–272., , , , , , et al.
- 33Meta-analysis of gene expression profiles in breast cancer: toward a unified understanding of breast cancer subtyping and prognosis signatures. Breast Cancer Res 2008; 10: R65., , , , , , et al.
- 34Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res 2007; 9: R65., , , , , , et al.
- 35Local recurrence after breast-conserving therapy in relation to gene expression patterns in a large series of patients. Clin Cancer Res 2009; 15: 4181–4190., , , , , , et al.
- 36Mucinous and neuroendocrine breast carcinomas are transcriptionally distinct from invasive ductal carcinomas of no special type. Mod Pathol 2009; epub ahead of print (doi:10.1038/modpathol.2009.112)., , , , , .
- 37The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 2006; 7: 96., , , , , , et al.
- 38Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 1998; 95: 14863–14868., , , .
- 39Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001; 98: 5116–5121., , .
- 40Metaplastic breast carcinomas are basal-like breast cancers: a genomic profiling analysis. Breast Cancer Res Treat 2009; 117:: 273–278., , .
- 41Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines. Lab Invest 2008; 88: 491–503., , , , , , et al.
- 42Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004; 10: 5367–5374., , , , , , et al.
- 43Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis. Clin Cancer Res 2007; 13: 90–101., , , , , , et al.
- 44Caveolin 1 and caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype. Br J Cancer 2008; 99: 327–334., , , , , , et al.
- 45High frequency of coexistence of columnar cell lesions, lobular neoplasia, and low grade ductal carcinoma in situ with invasive tubular carcinoma and invasive lobular carcinoma. Am J Surg Pathol 2007; 31: 417–426., , , , , .
- 46Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 2008; 32: 513–523., , , , , .
- 47Targeting tumour hypoxia in breast cancer. Eur J Cancer 2008; 44: 2766–2773., .
- 48ADAM9 as a potential target molecule in cancer. Curr Pharm Des 2009; 15: 2282–2287..
- 49Global gene expression profiling unveils S100A8/A9 as candidate markers in H-ras-mediated human breast epithelial cell invasion. Mol Cancer Res 2008; 6: 1544–1553., , , , , , et al.
- 50Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer. Breast Cancer Res Treat 2006; 99: 85–90., , , , .
- 51Molecular portraits of human breast tumours. Nature 2000; 406: 747–752., , , , , , et al.
- 52Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines. Oncogene 1999; 18: 1881–1890., , , , , , et al.
- 53Stromal cell expression of caveolin-1 predicts outcome in breast cancer. Am J Pathol 2009; 174: 2035–2043., , , , , , et al.
- 54The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy. Br J Cancer 2009; 100: 405–411., , , , , , et al.
- 55HIF-1alpha and CA IX staining in invasive breast carcinomas: prognosis and treatment outcome. Int J Cancer 2007; 120: 1451–1458., , , , , , et al.
- 56Molecular evolution of breast cancer. J Pathol 2005; 205: 248–254., , , .